Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark S Anderson

Showing results (171-180 of 194) with videos related to

Pageof 20
Sort By:
Medrxiv : the Preprint Server for Health Sciences|January 10, 2024
Unveiling the autoreactome: Proteome-wide immunological fingerprints reveal the promise of plasma cell depleting therapyAaron Bodansky, David Jl Yu, Alysa Rallistan, et al.
The Journal of Clinical Investigation|March 12, 2024
Neutralizing IFN-γ autoantibodies are rare and pathogenic in HLA-DRB1*15:02 or 16:02 individualsJessica N Peel, Rui Yang, Tom Le Voyer, et al.
Elife|October 27, 2022
Autoantibody discovery across monogenic, acquired, and COVID-19-associated autoimmunity with scalable PhIP-seqSara E Vazquez, Sabrina A Mann, Aaron Bodansky, et al.
Biorxiv : the Preprint Server for Biology|December 23, 2024
Altered Purinergic Signaling and CD8+ T Cell Dysregulation in STAT3 GOF SyndromeJose S Campos Duran, Samir Sayed, Megan C Dalalo, et al.
Nature|June 15, 2018
Author Correction: Discovery of stimulation-responsive immune enhancers with CRISPR activationDimitre R Simeonov, Benjamin G Gowen, Mandy Boontanrart, et al.
Nature|August 31, 2017
Discovery of stimulation-responsive immune enhancers with CRISPR activationDimitre R Simeonov, Benjamin G Gowen, Mandy Boontanrart, et al.
Science (New York, N.Y.)|September 16, 2021
Response to Comments on "Aberrant type 1 immunity drives susceptibility to mucosal fungal infections"Timothy J Break, Vasileios Oikonomou, Nicolas Dutzan, et al.
Nature Genetics|April 21, 2015
COPA mutations impair ER-Golgi transport and cause hereditary autoimmune-mediated lung disease and arthritisLevi B Watkin, Birthe Jessen, Wojciech Wiszniewski, et al.
Science (New York, N.Y.)|January 15, 2021
Aberrant type 1 immunity drives susceptibility to mucosal fungal infectionsTimothy J Break, Vasileios Oikonomou, Nicolas Dutzan, et al.
Science Translational Medicine|June 26, 2024
Transcobalamin receptor antibodies in autoimmune vitamin B12 central deficiencyJohn V Pluvinage, Thomas Ngo, Camille Fouassier, et al.
Pageof 20

Showing results (171-180 of 194) with videos related to

Sort By:
Pageof 20
Medrxiv : the Preprint Server for Health Sciences|January 10, 2024
Unveiling the autoreactome: Proteome-wide immunological fingerprints reveal the promise of plasma cell depleting therapyAaron Bodansky, David Jl Yu, Alysa Rallistan, et al.
The Journal of Clinical Investigation|March 12, 2024
Neutralizing IFN-γ autoantibodies are rare and pathogenic in HLA-DRB1*15:02 or 16:02 individualsJessica N Peel, Rui Yang, Tom Le Voyer, et al.
Elife|October 27, 2022
Autoantibody discovery across monogenic, acquired, and COVID-19-associated autoimmunity with scalable PhIP-seqSara E Vazquez, Sabrina A Mann, Aaron Bodansky, et al.
Biorxiv : the Preprint Server for Biology|December 23, 2024
Altered Purinergic Signaling and CD8+ T Cell Dysregulation in STAT3 GOF SyndromeJose S Campos Duran, Samir Sayed, Megan C Dalalo, et al.
Nature|June 15, 2018
Author Correction: Discovery of stimulation-responsive immune enhancers with CRISPR activationDimitre R Simeonov, Benjamin G Gowen, Mandy Boontanrart, et al.
Nature|August 31, 2017
Discovery of stimulation-responsive immune enhancers with CRISPR activationDimitre R Simeonov, Benjamin G Gowen, Mandy Boontanrart, et al.
Science (New York, N.Y.)|September 16, 2021
Response to Comments on "Aberrant type 1 immunity drives susceptibility to mucosal fungal infections"Timothy J Break, Vasileios Oikonomou, Nicolas Dutzan, et al.
Nature Genetics|April 21, 2015
COPA mutations impair ER-Golgi transport and cause hereditary autoimmune-mediated lung disease and arthritisLevi B Watkin, Birthe Jessen, Wojciech Wiszniewski, et al.
Science (New York, N.Y.)|January 15, 2021
Aberrant type 1 immunity drives susceptibility to mucosal fungal infectionsTimothy J Break, Vasileios Oikonomou, Nicolas Dutzan, et al.
Science Translational Medicine|June 26, 2024
Transcobalamin receptor antibodies in autoimmune vitamin B12 central deficiencyJohn V Pluvinage, Thomas Ngo, Camille Fouassier, et al.
Pageof 20